I'm a total fan of slow and steady wins the race. I'm also a fan of seeing the ink starting to dry on a deal. PLENTY of potential without a doubt. Just need to get it done. The EU theatre and U.S. trials are the way to go with a global partner. Use that partner to build the subsidiary and then announce the new protocols for brilacidin.